Similar Articles
Biological treatment in resistant adult-onset Still’s disease: A single-center, retrospective cohort study
Seda Çolak, Emre Tekgöz, Maghrur Mammadov, Muhammet Çınar, Sedat Yılmaz
DOI: 10.46497/ArchRheumatol.2022.8669
Issue: Volume 37 - Issue 1 - March 2022
2574
1709
Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
Dawei Lv, Xiaodong Zhao
DOI: 10.46497/ArchRheumatol.2023.9240
Issue: Volume 38 - Issue 1 - March 2023
1788
1597
Unmet needs in psoriatic arthritis, a narrative review
Clementina Lopez-Medina, Umut Kalyoncu, Laure Gossec
DOI: 10.46497/ArchRheumatol.2024.10710
Issue: Volume 39 - Issue 2 - June 2024
3177
1556
New and future perspectives in Behçet's syndrome
Bercemhan Sulu, Gulen Hatemi
DOI: 10.46497/ArchRheumatol.2024.11049
Issue: Volume 39 - Issue 4 - December 2024
1475
1288
Lung involvement is a risk factor for treatment resistance in patients with polymyositis and dermatomyositis
Elif Altunel Kılınç, Bengisu Ece Duman, Süleyman Özbek
DOI: 10.46497/ArchRheumatol.2025.10989
Issue: Volume 40 - Issue 1 - March 2025
172
132